- Home
- CTRN vs ETON Comparison
CTRN vs ETON Comparison
Compare CTRN & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTRN | ETON |
|---|---|---|
| Founded | 1946 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 382.6M | 411.9M |
| IPO Year | 2005 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CTRN | ETON |
|---|---|---|
| Price | $45.22 | $18.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $52.00 | $29.67 |
| AVG Volume (30 Days) | 58.1K | ★ 211.9K |
| Earning Date | 02-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $753,079,000.00 | $39,011,000.00 |
| Revenue This Year | $10.69 | $107.23 |
| Revenue Next Year | $5.15 | $29.72 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 0.69 | ★ 23.29 |
| 52 Week Low | $16.82 | $11.09 |
| 52 Week High | $49.50 | $23.00 |
Technical Indicators
Market Signals| Indicator | CTRN | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 45.40 | 73.62 |
| Support Level | $38.38 | $16.95 |
| Resistance Level | $48.78 | $20.03 |
| Average True Range (ATR) | 2.18 | 0.78 |
| MACD | -0.18 | 0.37 |
| Stochastic Oscillator | 18.81 | 98.98 |
Price Performance
Historical ComparisonAbout CTRN Citi Trends Inc.
Citi Trends Inc is a retailer of urban fashion apparel and accessories in the United States. The company offers apparel, including fashion sportswear for men and women, as well as children, such as newborns, infants, toddlers, boys, and girls; accessories comprising handbags, jewelry, footwear, belts, intimate apparel, scrubs, and sleepwear; and functional and decorative home products, as well as beauty products, books and toys.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.